NCT06682117
- Conditions
- Neoantigen, Solid Tumor Cancer, Treatment, +1 more
- Locations
-
- Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China
Clinical trial condition
Neoantigen
Explore clinical trials studying Neoantigen. Study availability and eligibility vary by location and protocol.
2 public trials
1 recruiting study
Neoantigen trial results
Enrolling by Invitation
Treatment of Relapsed or Refractory t(8; 21) AML With Targeted AML1-ETO Neoantigen Cytotoxic T Cells (CTL)
NCT06499025
- Conditions
- AML, Neoantigen, t(8;21)
- Locations
-
- Shenzhen University General Hospital Shenzhen, Guangdong, China